Search

Immunotherapy and Other Adjuvant Treatments

C001

OVEREXPRESSION OF HOMOLOGOUS REPAIR PROTEINS IN HUMAN PAPILLOMAVIRUS POSITIVE HEAD AND NECK SQUAMOUS CELL CARCINOMA BY IMMUNOHISTOCHEMISTRY ANALYSIS. A POTENTIAL TARGET FOR MOLECULAR THERAPIES.

Immunotherapy and Other Adjuvant Treatments

Andrew J Holcomb, MD1, Sufi Thomas, PhD1, Yelizaveta Shnayder, MD1, Rashna Madan, MD1, Ossama Tawfik, MD, PhD1, Nicholas Wallace, PhD2

1University of Kansas Medical Center, 2Kansas State University


C002

DEFINED GENETIC ALTERATIONS AS A BIOMARKER PREDICTING PROGNOSIS IN HPV-ASSOCIATED HEAD AND NECK CANCER.

Immunotherapy and Other Adjuvant Treatments

Andrew B Sewell, MD, Michael Hajek, MD, Cassie Pan, BS, Tejas Sather, BS, Wendell G Yarbrough, MD, MMHC, Natalia Issaeva, PhD

Yale University


C003

PLASMACYTOID DENDRITIC CELLS ARE DISTINCTLY IMMUNOSTIMULATORY IN HPV-POSITIVE HNSCC

Immunotherapy and Other Adjuvant Treatments

Kate Poropatich, Sandeep Samant, Bin Zhang

Northwestern University


C004

HIGH THROUGHPUT DRUG TESTING IDENTIFIES AGENTS WITH SELECTIVE ACTIVITY IN HPV-POSITIVE AND HPV-NEGATIVE CELL LINES

Immunotherapy and Other Adjuvant Treatments

Farhad Ghasemi, BSc1, Morgan D Black, BSc, MSc1, Alessandro Datti, PhD2, John W Barrett, PhD1, John Yoo, MD1, Kevin Fung, MD1, S D MacNeil, MD, MSc1, Anthony C Nichols, MD1

1Western University, 2Lunenfeld Tanenbaum Research Institute